Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02343549
Brief Title: A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

First Submitted : January 16, 2015
First Submitted that Met QC Criteria : January 16, 2015
First Posted : January 22, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 29, 2019
Last Update Posted : July 30, 2019